The Inflation Reduction Act of 2022 opens the door for Medicare to negotiate prices for certain drugs — a change that drug manufacturers strongly oppose.
Read the full post on Becker's Hospital Review - Healthcare News
Pharma giants slam Medicare drug price negotiation
